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Abstract This paper describes the process of dimer assembly of
mitochondrial very-long-chain acyl-CoA dehydrogenase
(VLCAD) subunit. Mature VLCAD is a homodimer of a 70-
kDa protein associated with the mitochondrial membrane. Newly
synthesized VLCAD was present as a monomer and the major
fraction was associated with the mitochondrial inner membrane.
The association of VLCAD subunit with the mitochondrial
membrane was observed early during dimer formation. In
contrast, a VLCAD monomeric mutant S583W, a novel
mutation identified from a patient with VLCAD deficiency, did
not associate with the mitochondrial membrane after import and
the major fraction remained in the mitochondrial matrix. These
results suggest that association of VLCAD protein with
mitochondrial inner membrane is necessary for dimer assembly
and formation of mature VLCAD.
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1. Introduction
Very-long-chain acyl-CoA dehydrogenase (VLCAD) is one
of four enzymes which catalyze the initial step of mitochon-
drial fatty acid L-oxidation spiral. These enzymes have over-
lapping substrate-chain-length speci¢cities. Three of the acyl-
CoA dehydrogenases are mitochondrial matrix proteins and
homotetramers of approximately 40-kDa polypeptides, where-
as VLCAD is an inner membrane-associated protein and a
homodimer of a 70-kDa polypeptide [1]. The amino-terminal
region of VLCAD shows signi¢cant sequence homology to
other acyl-CoA dehydrogenases. However, the carboxyl-ter-
minal has a long tail with approximately 180 amino acid res-
idues, which is not shared by other acyl-CoA dehydrogenases
[2,3].
We have studied the molecular basis of VLCAD de¢ciency.
This disease is a relatively recently identi¢ed inborn error of
the mitochondrial fatty acid oxidation system resulting in a
spectrum of ¢ndings noted in fatty acid oxidation disorders.
Clinical ¢ndings noted include hypertrophic cardiomyopathy,
skeletal myopathy, hypoglycemic hypoketonuria and sudden
infant death syndrome [4^8]. We previously identi¢ed 6 muta-
tions in VLCAD cDNAs from 6 patients with this disease
[3,9].
The mutations identi¢ed were shown to result in decreased
VLCAD activity in expression studies [9]. Post-translational
modi¢cation of VLCAD polypeptide to form the normal
VLCAD homodimer was impaired. Translational products
of the mutations located at the amino-terminal region
(E130del, K299del and K382Q) showed some degree of the
dimer formation, whereas R613W, only a mutation in the
carboxyl-terminal tail, was monomeric. We report the identi-
¢cation of a novel monomeric mutation in the carboxyl-ter-
minal sequence of VLCAD. In an attempt to further charac-
terize the process of VLCAD dimerization and the function of
the carboxyl-terminal sequence, we studied the process of
dimer assembly of native and a carboxyl-terminal mutant
VLCAD polypeptide.
2. Materials and methods
2.1. Patient
A female patient presented at 3 months of age with an acute epi-
sode of hypoketotic hypoglycemia and hypotonia. In addition to the
generalized hypotonia, marked hepatomegaly was noted. Evaluation
at that time revealed elevations in long chain acylcarnitine levels and
dicarboxylic aciduria. In skin ¢broblasts from this patient, the palmi-
toyl-CoA dehydrogenase activity was 0.37 mU/mg, which was signi¢-
cantly decreased compared to that in control (2.10 þ 0.31 mU/mg),
and cross-reactive protein with anti-VLCAD antibody was hardly
detected (data not shown).
2.2. Cell lines and cell culture
Chinese hamster ovary (CHO) cells transfected with pCXN2 vector
including VLCAD cDNA were previously described [9]. Skin ¢bro-
blasts from the patient and CHO cells were cultured in Dulbecco’s
modi¢ed Eagle’s medium containing 10% (v/v) fetal bovine serum, 0.1
mM non-essential amino acids (Gibco/BRL Oriental), 1U antibiotic-
antimycotic solution (Gibco/BRL Oriental), and 4.5 mg/ml glucose.
2.3. Cell labeling and gel-¢ltration analysis
The transfected cells were grown in 100-cm2 dishes. Before labeling,
the cells were incubated for 60 min in methionine-free modi¢ed Ea-
gle’s medium containing 5% (v/v) dialyzed fetal bovine serum. The
medium was replaced with the same medium containing 0.1 mCi of
[35S]methionine (Amersham Co., Amersham, UK) and the cells were
incubated for 10 min. In the case of chase, the medium was replaced
with a standard medium and the cells were further incubated for 20
min. The labeled cells were harvested and sonicated with 20 mM
potassium phosphate/0.15 M NaCl/0.2% Tween 20/1 mM PMSF.
The suspension was centrifuged at 100 000Ug for 30 min, and the
supernatant was applied to a G3000SW column (7.5 mm I.D.U60
cm; Tosoh, Tokyo, Japan) equilibrated with 20 mM potassium phos-
phate (pH 7.5)/0.15 M NaCl/0.2% Tween 20. The elution was per-
formed with the same bu¡er at a £ow rate of 1 ml/min, and each of
1 ml eluates was collected. Fractions were subjected to immunopreci-
pitation, SDS-PAGE and £uorography.
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2.4. Other methods
Methods for RNA isolation, PCR ampli¢cation, sequencing, vector
construction and transfection of CHO cells were described previously
[9].
3. Results and discussion
3.1. Expression of a novel mutant VLCAD
A C-1748-to-G transversion, which changes Ser-583 to Trp
(S583W), was identi¢ed in PCR-ampli¢ed cDNA from the
patient. Analysis of the family members for this mutation
revealed that the patient was a compound heterozygote with
the other allele having another mutation which could not be
identi¢ed in the present study because of signi¢cantly de-
creased level of its mRNA.
We performed cDNA-expression experiments of the novel
mutation using CHO cells. The palmitoyl-CoA dehydrogenase
activity in untransfected, VLCAD- and S583W-transfected
cells were 2.37, 12.3 and 2.29 mU/mg, respectively. Fig. 1A
shows the immuno£uorescence microscopy of untransfected
(panel 1), VLCAD- (panel 2) and S583W-(panel 3) transfected
cells. In the untransfected CHO cells, the signal was hardly
detected. On the other hand, an intense dotted £uorescence
pattern was observed in both VLCAD- and S583W-trans-
fected cells, indicating the expression of these proteins in the
cells. Similar staining of the cells was observed using Rhod-
amine 123, which stains mitochondria [10] (panel 4). Thus,
both the expressed VLCAD and S583W proteins were located
in mitochondria of the host cells. Mitochondrial import of
these proteins was also con¢rmed by the cell fractionation
analysis with proteinase treatment of separated mitochondria
(data not shown).
Fig. 1B shows the gel-¢ltration analysis of VLCAD and
S583W proteins expressed in CHO cells. Expressed VLCAD
was mainly eluted in fractions 19 and 20, of which the mo-
lecular mass was estimated to be 150 kDa, corresponding to
that of the puri¢ed enzyme. On the other hand, S583W pro-
tein was mainly detected in fractions 23 and 24, of which the
molecular mass was estimated to be 70 kDa, corresponding
with that of the monomeric subunit of VLCAD. The results
of gel-¢ltration analysis indicate that majority of soluble
S583W protein is present as a monomer in the host cells,
suggesting that the process of dimer assembly after normal
import into mitochondria is impaired. These observations
for S583W were similar to those for the previously identi¢ed
mutation, R613W [9].
3.2. Dimer assembly of VLCAD
To study the process of dimer assembly of VLCAD, the
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Fig. 1. Expression of VLCAD and S583W in CHO cells. A: immuno£uorescence microscopy of VLCAD- and S583W-transfected CHO cells
using anti-VLCAD antibody. Panel 1: untransfected cells; panel 2: VLCAD-transfected cells; panel 3: S583W-transfected cells ; panel 4: CHO
cells stained with Rhodamine 123. B: gel-¢ltration analysis. Protein standards used: E. coli L-galactosidase (465 kDa), rabbit muscle pyruvate
kinase (237 kDa), rabbit muscle lactate dehydrogenase (140 kDa), and bovine serum albumin (67 kDa).
Fig. 2. Gel-¢ltration analyses of 10-min labeled (a) and 20-min
chased cells (b). The result of £uorography was quanti¢ed and plot-
ted. A: VLCAD; B: S583W. V indicates the void fraction.
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transfected cells were brie£y labeled with [35S]methionine and
labeled VLCAD was analyzed by gel-¢ltration chromatogra-
phy. In cells labeled for 10 min, one peak of 35S-VLCAD was
found in fractions 23^25 (Fig. 2A). Newly synthesized (10
min-labeled) VLCAD was con¢rmed to be rapidly imported
into mitochondria, as it was mainly detected at the mature
size on SDS-PAGE/£uorography. In addition, newly synthe-
sized VLCAD was not degraded by the proteinase treatment
of separated mitochondria (data not shown). After chase for
20 min, the major peak of 35S-VLCAD was observed in frac-
tions 19^21, corresponding to the dimer with comparable den-
sity as that in the monomer fraction in the cells that were
labeled for 10 min. These results indicate that newly imported
VLCAD is present as a monomer followed by dimer assem-
bly, which occurs time dependently.
It is known that several newly imported mitochondrial pro-
teins form a complex with heat shock protein 60 (hsp60),
which promotes folding and assembly, and the release from
the complex with hsp60 requires ATP [11^13]. Saijo et al. [14]
demonstrated by in vitro translation/import experiments that
the folding and tetramer assembly of medium-chain acyl-CoA
dehydrogenase, a mitochondrial matrix protein, proceeds
ATP-dependently after formation of a high molecular weight
complex with hsp60 in mitochondria. Since the presence of
hsp60 in CHO cell mitochondria has been reported [15,16],
we expected that newly imported VLCAD would be found in
high molecular weight fractions if the dimer assembly of
VLCAD also required hsp60. However, no signal was de-
tected in high molecular weight fractions (fractions 11^20),
which would correspond to the predicted hsp60-acyl-CoA de-
hydrogenase complex (Fig. 2A). Additionally, cDNA-ex-
pressed VLCAD could form a homodimer, even if hsp60
was absent in CHO cells. This result suggests that hsp60
does not contribute to the dimer assembly of VLCAD. Since
the organization and structure of other mature acyl-CoA de-
hydrogenases and VLCAD are di¡erent, the mechanism of
complex assembly is di¡erent.
In a strain of yeast defective in mitochondrial hsp60 func-
tion, mitochondrial matrix-tergeted proteins were misfolded
and/or defective for import and sorting, whereas intramem-
brane space proteins such as cytochrome b2 and c1 and inner
membrane proteins such as cytochrome c oxidase subunit Va
and ADP/ATP carrier were normally imported and assembled
into the functional form [17,18]. Thus, hsp60 is likely to be
required for the matrix proteins in their folding and assembly,
but not for the intramembrane space and inner membrane
proteins.
3.3. Membrane association of newly imported VLCAD
Intact VLCAD is a mitochondrial inner membrane associ-
ated protein, although other acyl-CoA dehydrogenases are
matrix proteins. We examined the membrane association of
newly imported VLCAD subunit. The 10-min labeled or 20-
min chased cells were fractionated as soluble fractions without
(S1) and with 1% Triton X-100 (S2) and insoluble fraction (P).
In VLCAD transfected cells, most of 10-min labeled VLCAD
was detected in S2 fraction (Fig. 3), suggesting the membrane
association of newly imported VLCAD. The solubility of
VLCAD did not change after chase for 20 min and at a steady
state determined by immunoblotting. In contrast, 35S-S583W
in both 10-min labeled and 20-min chased cells, which existed
as a monomer (Fig. 2B), was mainly found in S1 fraction (Fig.
3). The same results were observed in the other monomeric
mutant R613W (data not shown). Thus, membrane associa-
tion of VLCAD subunit appears to be required for the proc-
ess of dimer assembly. Recently, some of the proteins which
have chaperone-like activity in mitochondrial inner membrane
have been identi¢ed [19]. Dimer processing and assembly of
VLCAD may be a function of or facilitated by these inner
membrane proteins.
A signi¢cant amount of S583W protein was insoluble at a
steady state, although the newly imported S583W was soluble
(Fig. 3). The half-life of S583W protein was within 6 h,
although that of normal VLCAD was more than 24 h.
Also, we previously identi¢ed four labile mutant VLCAD
[9], and con¢rmed that signi¢cant amounts of these transla-
tional products were insoluble (unpublished observation). In-
solubility of these mutant proteins may relate to their rapid
degradation, perhaps including the complex formation with
the degradation factors.
These results indicated that VLCAD protein associates with
the mitochondrial inner membrane and that dimerization to
form mature VLCAD occurs there. The S583W protein did
not associate with the inner membrane, raising the possibility
that the change in amino acid sequence interferes with normal
localization of the protein within the mitochondria. Whether
the localization of VLCAD is determined by the 180 amino
acid carboxyl-terminal sequence has not been determined.
These results would suggest a possible role for this sequence
and distinguish VLCAD from the other fatty acid acyl-CoA
dehydrogenases. The speci¢c steps and proteins involved in
localization and dimerization remain to be identi¢ed.
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